Felodipine–Metoprolol Combination Tablet: Maintained Health-Related Quality of Life in the Presence of Substantial Blood Pressure Reduction | Zendy

Björn Dahlöf | Zendy; Alessio Degl’Innocenti | Zendy; D ELMFELDT | Zendy; J PUIG | Zendy; Thomas E. Gundersen | Zendy; J Hosie | Zendy; W Januszewicź | Zendy; C LINDSTROM | Zendy; D Magometschnigg | Zendy; Paul H. Tanser | Zendy

Open Access

Felodipine–Metoprolol Combination Tablet: Maintained Health-Related Quality of Life in the Presence of Substantial Blood Pressure Reduction

Author(s) -

Björn Dahlöf,

Alessio Degl’Innocenti,

D ELMFELDT,

J PUIG,

Thomas E. Gundersen,

J Hosie,

W Januszewicź,

C LINDSTROM,

D Magometschnigg,

Paul H. Tanser

Publication year - 2005

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1016/j.amjhyper.2005.04.017

Subject(s) - medicine , felodipine , metoprolol , blood pressure , placebo , enalapril , diastole , quality of life (healthcare) , randomized controlled trial , hydrochlorothiazide , anesthesia , angiotensin converting enzyme , alternative medicine , nursing , pathology

Most treated hypertensive patients do not achieve adequate blood pressure (BP) control. Initiating therapy with two drugs has been suggested when BP is >20/10 mm Hg above goal. To ensure patients' compliance, such treatment needs to be well tolerated and must not compromise health-related quality of life (HRQL). The primary objective of this study was to compare the effects on HRQL of initiating treatment with felodipine + metoprolol (F+M) fixed combination tablets, or enalapril (E), or placebo (P).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research